Viewing Study NCT02486302


Ignite Creation Date: 2025-12-25 @ 4:01 AM
Ignite Modification Date: 2026-02-01 @ 10:05 AM
Study NCT ID: NCT02486302
Status: COMPLETED
Last Update Posted: 2019-06-24
First Post: 2015-06-28
Is Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study To Evaluate The Efficacy Of Enbrel (REGISTERED) Etanercept Over A Period Of 12 Months In The Routine Treatment Of Patients With Rheumatoid Arthritis, Axial Spondyloarthritis, Psoriatic Arthritis, Or Plaque Psoriasis.
Sponsor: Pfizer
Organization:

Key Dates - Follows AllAPIJSON File Order

Start Date: 2015-03-24
Start Date Type: ACTUAL
Primary Completion Date: 2017-12-11
Primary Completion Date Type: ACTUAL
Completion Date: 2017-12-11
Completion Date Type: ACTUAL
First Submit Date: 2015-06-28
First Submit QC Date: None
Study First Post Date: 2015-07-01
Study First Post Date Type: ESTIMATED
Results First Submit Date: 2018-11-12
Results First Submit QC Date: None
Results First Post Date: 2019-06-24
Results First Post Date Type: ACTUAL
Results First Post QC Date: None
Results First Post QC Date Type: None
Disp First Submit Date: None
Disp First Submit QC Date: None
Disp First Post Date: None
Disp First Post Date Type: None
Last Update Submit Date: 2019-03-29
Last Update Post Date: 2019-06-24
Last Update Post Date Type: ACTUAL